Clinical trial
Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are…
NCT00275015 · German CLL Study Group, Other · Completed
Key facts
| NCT number | NCT00275015 |
|---|---|
| Title | Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia |
| Official title | Pivotal Study for High Dose Therapy and Autologous Stem Cell Transplantation in Early Stages of CLL |
| Lead sponsor | German CLL Study Group, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Lymphocytic Leukemia |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, carmustine, cyclophosphamide, cytarabine, dexamethasone, etoposide, fludarabine phosphate, melphalan, bone marrow ablation with stem cell support, peripheral blood stem cell transplantation and 1 more |
| Enrollment | 169 |
| Start date | Jan 1, 1998 |
| Completion | Apr 1, 2012 |
| First posted | Jan 11, 2006 |
| Last update posted | May 11, 2018 |
| Countries | Austria, Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: